The controversial draft opioid prescribing guidelines released by the Centers for Disease Control have drawn scrutiny from a House of Representatives panel, which wants more information on a core expert group involved in developing the guidelines.
In a Dec. 18 letter to CDC’s director, Dr. Thomas Frieden, the House Committee on Oversight and Government Reform notes that the agency hasn’t identified the core expert group’s members. Oversight Committee members said they want to know why the CDC believes its core expert group is not an advisory committee under the Federal A...
Comments